The indirubin derivative 6-bromoindirubin-3'-glycerol-oxime ether (6BIGOE) potently modulates inflammatory cytokine and prostaglandin release from human monocytes through GSK-3 interference.


Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
10 2020
Historique:
received: 15 06 2020
revised: 20 07 2020
accepted: 20 07 2020
pubmed: 28 7 2020
medline: 1 1 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

Indirubin is a natural bis-indole alkaloid contained as active ingredient in the traditional Chinese remedy Danggui Longhui Wan. Indirubin and its 3'-oxime derivatives exhibit anti-cancer and anti-inflammatory properties and they inhibit glycogen synthase kinase (GSK)-3 in cell-free assays where 6-bromoindirubin-3'-oxime (6BIO) is among the most potent analogs. Here, we reveal 6-bromoindirubin-3'-glycerol-oxime ether (6BIGOE) as highly potent derivative able to inhibit pro-inflammatory cytokine, chemokine and prostaglandin (PG) release in human primary monocytes while increasing anti-inflammatory interleukin (IL)-10 levels. 6BIGOE suppressed lipopolysaccharide (LPS)-induced IL-1β and PGE

Identifiants

pubmed: 32710971
pii: S0006-2952(20)30406-8
doi: 10.1016/j.bcp.2020.114170
pii:
doi:

Substances chimiques

6-bromoindirubin-3'-oxime 0
Cytokines 0
Indoles 0
Inflammation Mediators 0
Oximes 0
Prostaglandin Antagonists 0
Prostaglandins 0
Glycogen Synthase Kinase 3 EC 2.7.11.26
indirubin V86L8P74GI

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114170

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Anna Czapka (A)

Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Philosophenweg 14, 07743 Jena, Germany. Electronic address: anna.czapka@uni-jena.de.

Stefanie König (S)

Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Philosophenweg 14, 07743 Jena, Germany. Electronic address: stefanie.koenig@uni-greifswald.de.

Carlo Pergola (C)

Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Philosophenweg 14, 07743 Jena, Germany. Electronic address: pergolacarlo@googlemail.com.

Christian Grune (C)

Pharmaceutical Technology and Biopharmacy, Institute of Pharmacy, Friedrich Schiller University Jena, Lessingstraße 8, 07743 Jena, Germany. Electronic address: christian.grune@uni-jena.de.

Konstantina Vougogiannopoulou (K)

Department of Pharmacy, Division of Pharmacognosy and Natural Products Chemistry, University of Athens, Panepistimiopolis Zografou, GR-15771 Athens, Greece. Electronic address: nadia_voug@pharm.uoa.gr.

Alexios-Leandros Skaltsounis (AL)

Department of Pharmacy, Division of Pharmacognosy and Natural Products Chemistry, University of Athens, Panepistimiopolis Zografou, GR-15771 Athens, Greece. Electronic address: skaltsounis@pharm.uoa.gr.

Dagmar Fischer (D)

Pharmaceutical Technology and Biopharmacy, Institute of Pharmacy, Friedrich Schiller University Jena, Lessingstraße 8, 07743 Jena, Germany. Electronic address: dagmar.fischer@uni-jena.de.

Oliver Werz (O)

Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Philosophenweg 14, 07743 Jena, Germany. Electronic address: oliver.werz@uni-jena.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH